Copyright
©The Author(s) 2024.
World J Diabetes. Jun 15, 2024; 15(6): 1234-1241
Published online Jun 15, 2024. doi: 10.4239/wjd.v15.i6.1234
Published online Jun 15, 2024. doi: 10.4239/wjd.v15.i6.1234
Table 3 Comparison of adverse reaction rates, n (%)
Adverse reactions | Observation group (n = 42) | Control group (n = 40) | χ2 | P value |
Conjunctival hyperemia | 2 (4.76) | 1 (2.50) | - | - |
Aggravated lacrimal gland injury | 1 (2.38) | 1 (2.50) | - | - |
Local inflammation | 0 | 1 (2.50) | - | - |
Corneal erosion | 2 (4.76) | 2 (5.00) | - | - |
Adverse reaction rate | 5 (11.90) | 5 (12.50) | 0.007 | 0.934 |
- Citation: Li JL, Zhao J, Guo ZF, Xiao C, Liu X. Efficacy of recombinant human epidermal growth factor plus sodium hyaluronate eye drops in diabetic dry eye post-cataract surgery. World J Diabetes 2024; 15(6): 1234-1241
- URL: https://www.wjgnet.com/1948-9358/full/v15/i6/1234.htm
- DOI: https://dx.doi.org/10.4239/wjd.v15.i6.1234